nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—kidney cancer	0.245	0.5	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—kidney cancer	0.245	0.5	CiPCiCtD
Clofarabine—RRM2—Gemcitabine—kidney cancer	0.0584	0.237	CbGbCtD
Clofarabine—RRM1—Gemcitabine—kidney cancer	0.0584	0.237	CbGbCtD
Clofarabine—Cytarabine—Gemcitabine—kidney cancer	0.0556	0.35	CrCrCtD
Clofarabine—Azacitidine—Gemcitabine—kidney cancer	0.0528	0.333	CrCrCtD
Clofarabine—POLA1—Gemcitabine—kidney cancer	0.0505	0.205	CbGbCtD
Clofarabine—Decitabine—Gemcitabine—kidney cancer	0.0503	0.317	CrCrCtD
Clofarabine—DCK—Gemcitabine—kidney cancer	0.0311	0.126	CbGbCtD
Clofarabine—ABCG2—Pazopanib—kidney cancer	0.00916	0.0372	CbGbCtD
Clofarabine—ABCG2—Dactinomycin—kidney cancer	0.00837	0.034	CbGbCtD
Clofarabine—ABCG2—Erlotinib—kidney cancer	0.00653	0.0265	CbGbCtD
Clofarabine—ABCG2—Paclitaxel—kidney cancer	0.00598	0.0243	CbGbCtD
Clofarabine—ABCG2—Sorafenib—kidney cancer	0.00531	0.0216	CbGbCtD
Clofarabine—ABCG2—Vincristine—kidney cancer	0.00516	0.0209	CbGbCtD
Clofarabine—ABCG2—Sunitinib—kidney cancer	0.0043	0.0175	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—kidney cancer	0.00322	0.0131	CbGbCtD
Clofarabine—RRM2—renal system—kidney cancer	0.000561	0.0948	CbGeAlD
Clofarabine—RRM2—kidney—kidney cancer	0.000542	0.0916	CbGeAlD
Clofarabine—RRM1—nephron tubule—kidney cancer	0.000513	0.0866	CbGeAlD
Clofarabine—RRM2—gonad—kidney cancer	0.000503	0.085	CbGeAlD
Clofarabine—Adenosine monophosphate—APRT—kidney cancer	0.0005	1	CrCbGaD
Clofarabine—RRM1—renal system—kidney cancer	0.000466	0.0787	CbGeAlD
Clofarabine—RRM1—kidney—kidney cancer	0.000451	0.0761	CbGeAlD
Clofarabine—RRM1—cortex of kidney—kidney cancer	0.000439	0.0741	CbGeAlD
Clofarabine—RRM1—gonad—kidney cancer	0.000418	0.0706	CbGeAlD
Clofarabine—RRM1—cardiac atrium—kidney cancer	0.000417	0.0705	CbGeAlD
Clofarabine—DCK—nephron tubule—kidney cancer	0.000398	0.0673	CbGeAlD
Clofarabine—DCK—cortex of kidney—kidney cancer	0.000341	0.0576	CbGeAlD
Clofarabine—DCK—gonad—kidney cancer	0.000325	0.0548	CbGeAlD
Clofarabine—DCK—cardiac atrium—kidney cancer	0.000324	0.0548	CbGeAlD
Clofarabine—RRM2—Gefitinib—Erlotinib—kidney cancer	0.000278	0.2	CbGdCrCtD
Clofarabine—ABCG2—nephron tubule—kidney cancer	0.000222	0.0375	CbGeAlD
Clofarabine—RRM2—Vinorelbine—Vinblastine—kidney cancer	0.000186	0.134	CbGdCrCtD
Clofarabine—RRM2—Vinorelbine—Vincristine—kidney cancer	0.000186	0.134	CbGdCrCtD
Clofarabine—POLA1—Vinblastine—Vincristine—kidney cancer	0.000176	0.127	CbGdCrCtD
Clofarabine—DCK—Sirolimus—Everolimus—kidney cancer	0.000158	0.114	CbGdCrCtD
Clofarabine—DCK—Sirolimus—Temsirolimus—kidney cancer	0.000158	0.114	CbGdCrCtD
Clofarabine—RRM1—Azacitidine—Gemcitabine—kidney cancer	0.00012	0.086	CbGdCrCtD
Clofarabine—RRM2—Azacitidine—Gemcitabine—kidney cancer	7.51e-05	0.054	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Doxorubicin—kidney cancer	5.1e-05	0.0367	CbGdCrCtD
Clofarabine—RRM1—Metabolism—GLIPR1—kidney cancer	4.4e-05	0.00177	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	4.31e-05	0.00173	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	4.25e-05	0.00171	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	4.19e-05	0.00169	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CCBL1—kidney cancer	4.18e-05	0.00168	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	4.15e-05	0.00167	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PDHB—kidney cancer	4.15e-05	0.00167	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	4.13e-05	0.00166	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—FH—kidney cancer	4.09e-05	0.00164	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APRT—kidney cancer	4.09e-05	0.00164	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	4.08e-05	0.00164	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	4.06e-05	0.00163	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	4.06e-05	0.00163	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	4.03e-05	0.00162	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PSMD7—kidney cancer	4.02e-05	0.00162	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	3.95e-05	0.00159	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.94e-05	0.00159	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—AURKA—kidney cancer	3.91e-05	0.00157	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CCBL1—kidney cancer	3.9e-05	0.00157	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—kidney cancer	3.87e-05	0.00156	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GPC3—kidney cancer	3.84e-05	0.00155	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RYR1—kidney cancer	3.81e-05	0.00153	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—kidney cancer	3.8e-05	0.00153	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	3.76e-05	0.00151	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CA2—kidney cancer	3.74e-05	0.0015	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.73e-05	0.0015	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—kidney cancer	3.69e-05	0.00148	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PSMD7—kidney cancer	3.68e-05	0.00148	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—kidney cancer	3.65e-05	0.00147	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALAD—kidney cancer	3.64e-05	0.00147	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.63e-05	0.00146	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GLIPR1—kidney cancer	3.62e-05	0.00146	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPAT—kidney cancer	3.62e-05	0.00146	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PSMD7—kidney cancer	3.6e-05	0.00145	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.56e-05	0.00143	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ST3GAL2—kidney cancer	3.56e-05	0.00143	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.56e-05	0.00143	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.53e-05	0.00142	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—AURKA—kidney cancer	3.5e-05	0.00141	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALDH1A1—kidney cancer	3.47e-05	0.0014	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—kidney cancer	3.47e-05	0.0014	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.44e-05	0.00138	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—CDKN1B—kidney cancer	3.42e-05	0.00138	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	3.42e-05	0.00137	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.39e-05	0.00136	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPAT—kidney cancer	3.38e-05	0.00136	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GLIPR1—kidney cancer	3.38e-05	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FH—kidney cancer	3.37e-05	0.00135	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—APRT—kidney cancer	3.37e-05	0.00135	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PGK1—kidney cancer	3.33e-05	0.00134	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SLC5A3—kidney cancer	3.33e-05	0.00134	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—CDKN1B—kidney cancer	3.29e-05	0.00133	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—LDHB—kidney cancer	3.27e-05	0.00131	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GPC3—kidney cancer	3.16e-05	0.00127	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APRT—kidney cancer	3.14e-05	0.00126	CbGpPWpGaD
Clofarabine—DCK—Metabolism—FH—kidney cancer	3.14e-05	0.00126	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	3.14e-05	0.00126	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—kidney cancer	3.11e-05	0.00125	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	3.11e-05	0.00125	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CA2—kidney cancer	3.08e-05	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	3.02e-05	0.00121	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALAD—kidney cancer	3e-05	0.00121	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1B—kidney cancer	2.99e-05	0.0012	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPC3—kidney cancer	2.96e-05	0.00119	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—kidney cancer	2.94e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.94e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.94e-05	0.00118	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ST3GAL2—kidney cancer	2.93e-05	0.00118	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.93e-05	0.00118	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CA2—kidney cancer	2.88e-05	0.00116	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALDH1A1—kidney cancer	2.86e-05	0.00115	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.86e-05	0.00115	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—kidney cancer	2.85e-05	0.00115	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CA9—kidney cancer	2.83e-05	0.00114	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALAD—kidney cancer	2.8e-05	0.00113	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.8e-05	0.00112	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	2.78e-05	0.00112	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PSMD7—kidney cancer	2.75e-05	0.00111	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC5A3—kidney cancer	2.74e-05	0.0011	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PGK1—kidney cancer	2.74e-05	0.0011	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ST3GAL2—kidney cancer	2.74e-05	0.0011	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LDHB—kidney cancer	2.69e-05	0.00108	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—AURKA—kidney cancer	2.68e-05	0.00108	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALDH1A1—kidney cancer	2.67e-05	0.00108	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BRCA2—kidney cancer	2.65e-05	0.00107	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—kidney cancer	2.65e-05	0.00107	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.64e-05	0.00106	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2B—kidney cancer	2.63e-05	0.00106	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	2.61e-05	0.00105	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A3—kidney cancer	2.56e-05	0.00103	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PGK1—kidney cancer	2.56e-05	0.00103	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—JUN—kidney cancer	2.56e-05	0.00103	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—BIRC5—kidney cancer	2.54e-05	0.00102	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—kidney cancer	2.52e-05	0.00101	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LDHB—kidney cancer	2.51e-05	0.00101	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	2.48e-05	0.000997	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PSMD7—kidney cancer	2.46e-05	0.00099	CbGpPWpGaD
Clofarabine—Paraesthesia—Vincristine—kidney cancer	2.46e-05	0.000339	CcSEcCtD
Clofarabine—Agitation—Paclitaxel—kidney cancer	2.45e-05	0.000338	CcSEcCtD
Clofarabine—Rash—Everolimus—kidney cancer	2.44e-05	0.000337	CcSEcCtD
Clofarabine—Dermatitis—Everolimus—kidney cancer	2.44e-05	0.000337	CcSEcCtD
Clofarabine—Headache—Vinblastine—kidney cancer	2.44e-05	0.000336	CcSEcCtD
Clofarabine—Headache—Everolimus—kidney cancer	2.43e-05	0.000335	CcSEcCtD
Clofarabine—Hypotension—Gemcitabine—kidney cancer	2.43e-05	0.000335	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.43e-05	0.000976	CbGpPWpGaD
Clofarabine—Abdominal pain—Dactinomycin—kidney cancer	2.42e-05	0.000334	CcSEcCtD
Clofarabine—Body temperature increased—Dactinomycin—kidney cancer	2.42e-05	0.000334	CcSEcCtD
Clofarabine—Asthenia—Sorafenib—kidney cancer	2.41e-05	0.000333	CcSEcCtD
Clofarabine—RRM1—Metabolism—CRABP1—kidney cancer	2.41e-05	0.000969	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—AURKA—kidney cancer	2.39e-05	0.000963	CbGpPWpGaD
Clofarabine—Lethargy—Doxorubicin—kidney cancer	2.39e-05	0.00033	CcSEcCtD
Clofarabine—Leukopenia—Paclitaxel—kidney cancer	2.39e-05	0.000329	CcSEcCtD
Clofarabine—Hypersensitivity—Sunitinib—kidney cancer	2.39e-05	0.000329	CcSEcCtD
Clofarabine—Decreased appetite—Vincristine—kidney cancer	2.38e-05	0.000329	CcSEcCtD
Clofarabine—Pruritus—Sorafenib—kidney cancer	2.38e-05	0.000329	CcSEcCtD
Clofarabine—Vomiting—Erlotinib—kidney cancer	2.38e-05	0.000328	CcSEcCtD
Clofarabine—Erythema multiforme—Capecitabine—kidney cancer	2.38e-05	0.000328	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.37e-05	0.000327	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Vincristine—kidney cancer	2.36e-05	0.000326	CcSEcCtD
Clofarabine—Fatigue—Vincristine—kidney cancer	2.36e-05	0.000326	CcSEcCtD
Clofarabine—Rash—Erlotinib—kidney cancer	2.36e-05	0.000325	CcSEcCtD
Clofarabine—Dermatitis—Erlotinib—kidney cancer	2.36e-05	0.000325	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.35e-05	0.000944	CbGpPWpGaD
Clofarabine—Headache—Erlotinib—kidney cancer	2.34e-05	0.000323	CcSEcCtD
Clofarabine—Pain—Vincristine—kidney cancer	2.34e-05	0.000323	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.34e-05	0.000323	CcSEcCtD
Clofarabine—Pain in extremity—Doxorubicin—kidney cancer	2.34e-05	0.000323	CcSEcCtD
Clofarabine—Paraesthesia—Gemcitabine—kidney cancer	2.33e-05	0.000322	CcSEcCtD
Clofarabine—RRM2—Metabolism—CA9—kidney cancer	2.33e-05	0.000938	CbGpPWpGaD
Clofarabine—Cardiac disorder—Capecitabine—kidney cancer	2.33e-05	0.000322	CcSEcCtD
Clofarabine—Flushing—Capecitabine—kidney cancer	2.33e-05	0.000322	CcSEcCtD
Clofarabine—Cough—Paclitaxel—kidney cancer	2.33e-05	0.000321	CcSEcCtD
Clofarabine—Asthenia—Sunitinib—kidney cancer	2.32e-05	0.000321	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—kidney cancer	2.32e-05	0.000933	CbGpPWpGaD
Clofarabine—Dyspnoea—Gemcitabine—kidney cancer	2.32e-05	0.00032	CcSEcCtD
Clofarabine—Nausea—Vinblastine—kidney cancer	2.31e-05	0.000319	CcSEcCtD
Clofarabine—Somnolence—Gemcitabine—kidney cancer	2.31e-05	0.000319	CcSEcCtD
Clofarabine—Nausea—Everolimus—kidney cancer	2.3e-05	0.000318	CcSEcCtD
Clofarabine—Diarrhoea—Sorafenib—kidney cancer	2.3e-05	0.000318	CcSEcCtD
Clofarabine—Hypertension—Paclitaxel—kidney cancer	2.3e-05	0.000318	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.3e-05	0.000923	CbGpPWpGaD
Clofarabine—Pruritus—Sunitinib—kidney cancer	2.29e-05	0.000316	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—kidney cancer	2.29e-05	0.000921	CbGpPWpGaD
Clofarabine—Angiopathy—Capecitabine—kidney cancer	2.28e-05	0.000315	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.27e-05	0.000914	CbGpPWpGaD
Clofarabine—Immune system disorder—Capecitabine—kidney cancer	2.27e-05	0.000313	CcSEcCtD
Clofarabine—Arthralgia—Paclitaxel—kidney cancer	2.27e-05	0.000313	CcSEcCtD
Clofarabine—Myalgia—Paclitaxel—kidney cancer	2.27e-05	0.000313	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—BIRC5—kidney cancer	2.27e-05	0.000912	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Capecitabine—kidney cancer	2.26e-05	0.000312	CcSEcCtD
Clofarabine—Anxiety—Paclitaxel—kidney cancer	2.26e-05	0.000312	CcSEcCtD
Clofarabine—Decreased appetite—Gemcitabine—kidney cancer	2.26e-05	0.000312	CcSEcCtD
Clofarabine—Hypersensitivity—Dactinomycin—kidney cancer	2.26e-05	0.000312	CcSEcCtD
Clofarabine—Chills—Capecitabine—kidney cancer	2.25e-05	0.000311	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.25e-05	0.000311	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.24e-05	0.00031	CcSEcCtD
Clofarabine—Fatigue—Gemcitabine—kidney cancer	2.24e-05	0.000309	CcSEcCtD
Clofarabine—Gastrointestinal pain—Vincristine—kidney cancer	2.24e-05	0.000309	CcSEcCtD
Clofarabine—RRM1—Metabolism—ITPR2—kidney cancer	2.24e-05	0.000901	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	2.24e-05	0.0009	CbGpPWpGaD
Clofarabine—Dizziness—Sorafenib—kidney cancer	2.23e-05	0.000307	CcSEcCtD
Clofarabine—Pain—Gemcitabine—kidney cancer	2.22e-05	0.000307	CcSEcCtD
Clofarabine—Nausea—Erlotinib—kidney cancer	2.22e-05	0.000307	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.22e-05	0.000893	CbGpPWpGaD
Clofarabine—Alopecia—Capecitabine—kidney cancer	2.22e-05	0.000306	CcSEcCtD
Clofarabine—Diarrhoea—Sunitinib—kidney cancer	2.22e-05	0.000306	CcSEcCtD
Clofarabine—Mental disorder—Capecitabine—kidney cancer	2.2e-05	0.000304	CcSEcCtD
Clofarabine—Asthenia—Dactinomycin—kidney cancer	2.2e-05	0.000303	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—kidney cancer	2.19e-05	0.000303	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.19e-05	0.000881	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.19e-05	0.000881	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.19e-05	0.000881	CbGpPWpGaD
Clofarabine—Erythema—Capecitabine—kidney cancer	2.19e-05	0.000302	CcSEcCtD
Clofarabine—Malnutrition—Capecitabine—kidney cancer	2.19e-05	0.000302	CcSEcCtD
Clofarabine—DCK—Metabolism—CA9—kidney cancer	2.18e-05	0.000877	CbGpPWpGaD
Clofarabine—Dehydration—Doxorubicin—kidney cancer	2.18e-05	0.0003	CcSEcCtD
Clofarabine—Oedema—Paclitaxel—kidney cancer	2.18e-05	0.0003	CcSEcCtD
Clofarabine—Body temperature increased—Vincristine—kidney cancer	2.17e-05	0.000299	CcSEcCtD
Clofarabine—Abdominal pain—Vincristine—kidney cancer	2.17e-05	0.000299	CcSEcCtD
Clofarabine—Infection—Paclitaxel—kidney cancer	2.16e-05	0.000298	CcSEcCtD
Clofarabine—Dry skin—Doxorubicin—kidney cancer	2.15e-05	0.000296	CcSEcCtD
Clofarabine—Dizziness—Sunitinib—kidney cancer	2.14e-05	0.000295	CcSEcCtD
Clofarabine—Feeling abnormal—Gemcitabine—kidney cancer	2.14e-05	0.000295	CcSEcCtD
Clofarabine—Vomiting—Sorafenib—kidney cancer	2.14e-05	0.000295	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—kidney cancer	2.14e-05	0.000295	CcSEcCtD
Clofarabine—Nervous system disorder—Paclitaxel—kidney cancer	2.13e-05	0.000294	CcSEcCtD
Clofarabine—Thrombocytopenia—Paclitaxel—kidney cancer	2.13e-05	0.000294	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—kidney cancer	2.12e-05	0.000855	CbGpPWpGaD
Clofarabine—Tachycardia—Paclitaxel—kidney cancer	2.12e-05	0.000293	CcSEcCtD
Clofarabine—Rash—Sorafenib—kidney cancer	2.12e-05	0.000293	CcSEcCtD
Clofarabine—Dermatitis—Sorafenib—kidney cancer	2.12e-05	0.000293	CcSEcCtD
Clofarabine—Back pain—Capecitabine—kidney cancer	2.12e-05	0.000292	CcSEcCtD
Clofarabine—Skin disorder—Paclitaxel—kidney cancer	2.11e-05	0.000292	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.11e-05	0.000291	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	2.11e-05	0.000291	CcSEcCtD
Clofarabine—Headache—Sorafenib—kidney cancer	2.11e-05	0.000291	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.1e-05	0.000846	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Paclitaxel—kidney cancer	2.1e-05	0.00029	CcSEcCtD
Clofarabine—Diarrhoea—Dactinomycin—kidney cancer	2.1e-05	0.000289	CcSEcCtD
Clofarabine—Anorexia—Paclitaxel—kidney cancer	2.07e-05	0.000286	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	2.07e-05	0.000285	CcSEcCtD
Clofarabine—Vomiting—Sunitinib—kidney cancer	2.06e-05	0.000284	CcSEcCtD
Clofarabine—Body temperature increased—Gemcitabine—kidney cancer	2.05e-05	0.000283	CcSEcCtD
Clofarabine—Tremor—Capecitabine—kidney cancer	2.05e-05	0.000283	CcSEcCtD
Clofarabine—RRM1—Metabolism—ACHE—kidney cancer	2.04e-05	0.000821	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTT1—kidney cancer	2.04e-05	0.000821	CbGpPWpGaD
Clofarabine—Rash—Sunitinib—kidney cancer	2.04e-05	0.000282	CcSEcCtD
Clofarabine—Dermatitis—Sunitinib—kidney cancer	2.04e-05	0.000281	CcSEcCtD
Clofarabine—Hypotension—Paclitaxel—kidney cancer	2.03e-05	0.00028	CcSEcCtD
Clofarabine—Headache—Sunitinib—kidney cancer	2.03e-05	0.00028	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—kidney cancer	2.02e-05	0.000279	CcSEcCtD
Clofarabine—Anaemia—Capecitabine—kidney cancer	2.02e-05	0.000279	CcSEcCtD
Clofarabine—Hypersensitivity—Vincristine—kidney cancer	2.02e-05	0.000278	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.01e-05	0.000809	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.01e-05	0.000807	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2e-05	0.000805	CbGpPWpGaD
Clofarabine—Nausea—Sorafenib—kidney cancer	2e-05	0.000276	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.99e-05	0.000799	CbGpPWpGaD
Clofarabine—Pancreatitis—Doxorubicin—kidney cancer	1.98e-05	0.000274	CcSEcCtD
Clofarabine—RRM2—Metabolism—CRABP1—kidney cancer	1.98e-05	0.000798	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.98e-05	0.000273	CcSEcCtD
Clofarabine—Asthenia—Vincristine—kidney cancer	1.97e-05	0.000271	CcSEcCtD
Clofarabine—Leukopenia—Capecitabine—kidney cancer	1.96e-05	0.00027	CcSEcCtD
Clofarabine—Paraesthesia—Paclitaxel—kidney cancer	1.95e-05	0.00027	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ACY1—kidney cancer	1.95e-05	0.000786	CbGpPWpGaD
Clofarabine—Vomiting—Dactinomycin—kidney cancer	1.95e-05	0.000269	CcSEcCtD
Clofarabine—Dyspnoea—Paclitaxel—kidney cancer	1.94e-05	0.000268	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.94e-05	0.000779	CbGpPWpGaD
Clofarabine—Somnolence—Paclitaxel—kidney cancer	1.93e-05	0.000267	CcSEcCtD
Clofarabine—Rash—Dactinomycin—kidney cancer	1.93e-05	0.000267	CcSEcCtD
Clofarabine—RRM1—Metabolism—SCARB1—kidney cancer	1.93e-05	0.000777	CbGpPWpGaD
Clofarabine—Nausea—Sunitinib—kidney cancer	1.92e-05	0.000265	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—kidney cancer	1.92e-05	0.000265	CcSEcCtD
Clofarabine—RRM1—Metabolism—PTGS1—kidney cancer	1.91e-05	0.00077	CbGpPWpGaD
Clofarabine—Cough—Capecitabine—kidney cancer	1.91e-05	0.000263	CcSEcCtD
Clofarabine—Neutropenia—Doxorubicin—kidney cancer	1.89e-05	0.000261	CcSEcCtD
Clofarabine—Decreased appetite—Paclitaxel—kidney cancer	1.89e-05	0.000261	CcSEcCtD
Clofarabine—Hypertension—Capecitabine—kidney cancer	1.89e-05	0.000261	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—kidney cancer	1.88e-05	0.00026	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Paclitaxel—kidney cancer	1.88e-05	0.000259	CcSEcCtD
Clofarabine—RRM1—Metabolism—PSMD7—kidney cancer	1.88e-05	0.000755	CbGpPWpGaD
Clofarabine—Fatigue—Paclitaxel—kidney cancer	1.88e-05	0.000259	CcSEcCtD
Clofarabine—Diarrhoea—Vincristine—kidney cancer	1.87e-05	0.000259	CcSEcCtD
Clofarabine—Asthenia—Gemcitabine—kidney cancer	1.86e-05	0.000257	CcSEcCtD
Clofarabine—Myalgia—Capecitabine—kidney cancer	1.86e-05	0.000257	CcSEcCtD
Clofarabine—Arthralgia—Capecitabine—kidney cancer	1.86e-05	0.000257	CcSEcCtD
Clofarabine—Pain—Paclitaxel—kidney cancer	1.86e-05	0.000257	CcSEcCtD
Clofarabine—Anxiety—Capecitabine—kidney cancer	1.86e-05	0.000256	CcSEcCtD
Clofarabine—DCK—Metabolism—CRABP1—kidney cancer	1.85e-05	0.000746	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	1.85e-05	0.000255	CcSEcCtD
Clofarabine—RRM2—Metabolism—ITPR2—kidney cancer	1.84e-05	0.000742	CbGpPWpGaD
Clofarabine—Pruritus—Gemcitabine—kidney cancer	1.84e-05	0.000254	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—kidney cancer	1.83e-05	0.000253	CcSEcCtD
Clofarabine—Nausea—Dactinomycin—kidney cancer	1.82e-05	0.000251	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—kidney cancer	1.81e-05	0.00025	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BRCA2—kidney cancer	1.81e-05	0.00073	CbGpPWpGaD
Clofarabine—Dizziness—Vincristine—kidney cancer	1.81e-05	0.00025	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—kidney cancer	1.8e-05	0.000249	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—kidney cancer	1.8e-05	0.000249	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN2B—kidney cancer	1.8e-05	0.000723	CbGpPWpGaD
Clofarabine—Feeling abnormal—Paclitaxel—kidney cancer	1.79e-05	0.000247	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	1.79e-05	0.000247	CcSEcCtD
Clofarabine—Oedema—Capecitabine—kidney cancer	1.79e-05	0.000246	CcSEcCtD
Clofarabine—Gastrointestinal pain—Paclitaxel—kidney cancer	1.78e-05	0.000245	CcSEcCtD
Clofarabine—RRM1—Metabolism—BCHE—kidney cancer	1.78e-05	0.000716	CbGpPWpGaD
Clofarabine—Diarrhoea—Gemcitabine—kidney cancer	1.78e-05	0.000245	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—kidney cancer	1.77e-05	0.000245	CcSEcCtD
Clofarabine—Infection—Capecitabine—kidney cancer	1.77e-05	0.000245	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—kidney cancer	1.77e-05	0.000244	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—kidney cancer	1.76e-05	0.000243	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—kidney cancer	1.76e-05	0.000243	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC5A5—kidney cancer	1.76e-05	0.000707	CbGpPWpGaD
Clofarabine—Nervous system disorder—Capecitabine—kidney cancer	1.75e-05	0.000242	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.75e-05	0.000704	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Capecitabine—kidney cancer	1.75e-05	0.000241	CcSEcCtD
Clofarabine—Tachycardia—Capecitabine—kidney cancer	1.74e-05	0.00024	CcSEcCtD
Clofarabine—Vomiting—Vincristine—kidney cancer	1.74e-05	0.00024	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—BIRC5—kidney cancer	1.74e-05	0.000698	CbGpPWpGaD
Clofarabine—Skin disorder—Capecitabine—kidney cancer	1.73e-05	0.000239	CcSEcCtD
Clofarabine—Rash—Vincristine—kidney cancer	1.73e-05	0.000238	CcSEcCtD
Clofarabine—Hyperhidrosis—Capecitabine—kidney cancer	1.73e-05	0.000238	CcSEcCtD
Clofarabine—Dermatitis—Vincristine—kidney cancer	1.73e-05	0.000238	CcSEcCtD
Clofarabine—DCK—Metabolism—ITPR2—kidney cancer	1.72e-05	0.000693	CbGpPWpGaD
Clofarabine—Haematuria—Doxorubicin—kidney cancer	1.72e-05	0.000237	CcSEcCtD
Clofarabine—Abdominal pain—Paclitaxel—kidney cancer	1.72e-05	0.000237	CcSEcCtD
Clofarabine—Body temperature increased—Paclitaxel—kidney cancer	1.72e-05	0.000237	CcSEcCtD
Clofarabine—Headache—Vincristine—kidney cancer	1.72e-05	0.000237	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—kidney cancer	1.71e-05	0.000235	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—kidney cancer	1.7e-05	0.000235	CcSEcCtD
Clofarabine—Anorexia—Capecitabine—kidney cancer	1.7e-05	0.000235	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC2A1—kidney cancer	1.7e-05	0.000683	CbGpPWpGaD
Clofarabine—Sinusitis—Doxorubicin—kidney cancer	1.69e-05	0.000234	CcSEcCtD
Clofarabine—RRM2—Metabolism—ACHE—kidney cancer	1.68e-05	0.000676	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTT1—kidney cancer	1.68e-05	0.000676	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.68e-05	0.000676	CbGpPWpGaD
Clofarabine—Hypotension—Capecitabine—kidney cancer	1.67e-05	0.00023	CcSEcCtD
Clofarabine—ABCG2—Metabolism—PDHB—kidney cancer	1.66e-05	0.000668	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.65e-05	0.000666	CbGpPWpGaD
Clofarabine—Vomiting—Gemcitabine—kidney cancer	1.65e-05	0.000228	CcSEcCtD
Clofarabine—Rash—Gemcitabine—kidney cancer	1.64e-05	0.000226	CcSEcCtD
Clofarabine—Dermatitis—Gemcitabine—kidney cancer	1.64e-05	0.000226	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—kidney cancer	1.63e-05	0.000225	CcSEcCtD
Clofarabine—Headache—Gemcitabine—kidney cancer	1.63e-05	0.000225	CcSEcCtD
Clofarabine—Nausea—Vincristine—kidney cancer	1.63e-05	0.000224	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	1.63e-05	0.000224	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—kidney cancer	1.62e-05	0.000223	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.61e-05	0.000647	CbGpPWpGaD
Clofarabine—Paraesthesia—Capecitabine—kidney cancer	1.6e-05	0.000221	CcSEcCtD
Clofarabine—Hypersensitivity—Paclitaxel—kidney cancer	1.6e-05	0.000221	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—kidney cancer	1.6e-05	0.000221	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—kidney cancer	1.6e-05	0.00022	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—kidney cancer	1.59e-05	0.00022	CcSEcCtD
Clofarabine—RRM2—Metabolism—SCARB1—kidney cancer	1.59e-05	0.00064	CbGpPWpGaD
Clofarabine—Dyspnoea—Capecitabine—kidney cancer	1.59e-05	0.00022	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—kidney cancer	1.59e-05	0.000219	CcSEcCtD
Clofarabine—RRM2—Metabolism—PTGS1—kidney cancer	1.58e-05	0.000634	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.57e-05	0.000633	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTT1—kidney cancer	1.57e-05	0.000632	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ACHE—kidney cancer	1.57e-05	0.000632	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CCBL1—kidney cancer	1.56e-05	0.000628	CbGpPWpGaD
Clofarabine—Asthenia—Paclitaxel—kidney cancer	1.56e-05	0.000215	CcSEcCtD
Clofarabine—Decreased appetite—Capecitabine—kidney cancer	1.55e-05	0.000214	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BIRC5—kidney cancer	1.55e-05	0.000624	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PSMD7—kidney cancer	1.55e-05	0.000622	CbGpPWpGaD
Clofarabine—Nausea—Gemcitabine—kidney cancer	1.54e-05	0.000213	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Capecitabine—kidney cancer	1.54e-05	0.000213	CcSEcCtD
Clofarabine—Fatigue—Capecitabine—kidney cancer	1.54e-05	0.000212	CcSEcCtD
Clofarabine—Pruritus—Paclitaxel—kidney cancer	1.54e-05	0.000212	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—kidney cancer	1.53e-05	0.000211	CcSEcCtD
Clofarabine—Pain—Capecitabine—kidney cancer	1.53e-05	0.000211	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—kidney cancer	1.5e-05	0.000207	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—kidney cancer	1.5e-05	0.000207	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2A—kidney cancer	1.5e-05	0.000605	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.49e-05	0.000599	CbGpPWpGaD
Clofarabine—Diarrhoea—Paclitaxel—kidney cancer	1.49e-05	0.000205	CcSEcCtD
Clofarabine—DCK—Metabolism—SCARB1—kidney cancer	1.49e-05	0.000598	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.49e-05	0.000598	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS1—kidney cancer	1.47e-05	0.000592	CbGpPWpGaD
Clofarabine—Feeling abnormal—Capecitabine—kidney cancer	1.47e-05	0.000203	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—kidney cancer	1.47e-05	0.000203	CcSEcCtD
Clofarabine—RRM2—Metabolism—BCHE—kidney cancer	1.46e-05	0.000589	CbGpPWpGaD
Clofarabine—Immune system disorder—Doxorubicin—kidney cancer	1.46e-05	0.000202	CcSEcCtD
Clofarabine—Gastrointestinal pain—Capecitabine—kidney cancer	1.46e-05	0.000201	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—kidney cancer	1.46e-05	0.000201	CcSEcCtD
Clofarabine—Chills—Doxorubicin—kidney cancer	1.45e-05	0.000201	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC5A5—kidney cancer	1.45e-05	0.000582	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PSMD7—kidney cancer	1.44e-05	0.000581	CbGpPWpGaD
Clofarabine—Dizziness—Paclitaxel—kidney cancer	1.44e-05	0.000198	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—kidney cancer	1.43e-05	0.000197	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—kidney cancer	1.42e-05	0.000571	CbGpPWpGaD
Clofarabine—Mental disorder—Doxorubicin—kidney cancer	1.42e-05	0.000196	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000569	CbGpPWpGaD
Clofarabine—Abdominal pain—Capecitabine—kidney cancer	1.41e-05	0.000195	CcSEcCtD
Clofarabine—Body temperature increased—Capecitabine—kidney cancer	1.41e-05	0.000195	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—kidney cancer	1.41e-05	0.000195	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—kidney cancer	1.41e-05	0.000195	CcSEcCtD
Clofarabine—RRM2—Metabolism—SLC2A1—kidney cancer	1.4e-05	0.000562	CbGpPWpGaD
Clofarabine—Vomiting—Paclitaxel—kidney cancer	1.38e-05	0.000191	CcSEcCtD
Clofarabine—Rash—Paclitaxel—kidney cancer	1.37e-05	0.000189	CcSEcCtD
Clofarabine—Dermatitis—Paclitaxel—kidney cancer	1.37e-05	0.000189	CcSEcCtD
Clofarabine—DCK—Metabolism—BCHE—kidney cancer	1.37e-05	0.000551	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.37e-05	0.00055	CbGpPWpGaD
Clofarabine—Back pain—Doxorubicin—kidney cancer	1.36e-05	0.000188	CcSEcCtD
Clofarabine—Headache—Paclitaxel—kidney cancer	1.36e-05	0.000188	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GLIPR1—kidney cancer	1.35e-05	0.000545	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPAT—kidney cancer	1.35e-05	0.000545	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A5—kidney cancer	1.35e-05	0.000544	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCB1—kidney cancer	1.34e-05	0.000539	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—kidney cancer	1.33e-05	0.000535	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.32e-05	0.000532	CbGpPWpGaD
Clofarabine—Hypersensitivity—Capecitabine—kidney cancer	1.32e-05	0.000181	CcSEcCtD
Clofarabine—DCK—Metabolism—SLC2A1—kidney cancer	1.31e-05	0.000525	CbGpPWpGaD
Clofarabine—Anaemia—Doxorubicin—kidney cancer	1.3e-05	0.00018	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTM1—kidney cancer	1.3e-05	0.000523	CbGpPWpGaD
Clofarabine—Agitation—Doxorubicin—kidney cancer	1.3e-05	0.000179	CcSEcCtD
Clofarabine—Nausea—Paclitaxel—kidney cancer	1.29e-05	0.000178	CcSEcCtD
Clofarabine—Asthenia—Capecitabine—kidney cancer	1.28e-05	0.000177	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—kidney cancer	1.27e-05	0.000511	CbGpPWpGaD
Clofarabine—Pruritus—Capecitabine—kidney cancer	1.26e-05	0.000174	CcSEcCtD
Clofarabine—Leukopenia—Doxorubicin—kidney cancer	1.26e-05	0.000174	CcSEcCtD
Clofarabine—ABCG2—Metabolism—APRT—kidney cancer	1.26e-05	0.000506	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FH—kidney cancer	1.26e-05	0.000506	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1A1—kidney cancer	1.23e-05	0.000496	CbGpPWpGaD
Clofarabine—Cough—Doxorubicin—kidney cancer	1.23e-05	0.00017	CcSEcCtD
Clofarabine—Diarrhoea—Capecitabine—kidney cancer	1.22e-05	0.000169	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—kidney cancer	1.22e-05	0.000168	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—kidney cancer	1.2e-05	0.000166	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—kidney cancer	1.2e-05	0.000166	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—kidney cancer	1.2e-05	0.000165	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.19e-05	0.000164	CcSEcCtD
Clofarabine—ABCG2—Metabolism—GPC3—kidney cancer	1.18e-05	0.000476	CbGpPWpGaD
Clofarabine—Dizziness—Capecitabine—kidney cancer	1.18e-05	0.000163	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.17e-05	0.000471	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—kidney cancer	1.17e-05	0.000469	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.16e-05	0.000465	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA2—kidney cancer	1.15e-05	0.000463	CbGpPWpGaD
Clofarabine—Oedema—Doxorubicin—kidney cancer	1.15e-05	0.000159	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.15e-05	0.000462	CbGpPWpGaD
Clofarabine—Infection—Doxorubicin—kidney cancer	1.14e-05	0.000158	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—kidney cancer	1.14e-05	0.000458	CbGpPWpGaD
Clofarabine—Vomiting—Capecitabine—kidney cancer	1.14e-05	0.000157	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—kidney cancer	1.13e-05	0.000156	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—kidney cancer	1.13e-05	0.000155	CcSEcCtD
Clofarabine—Rash—Capecitabine—kidney cancer	1.13e-05	0.000155	CcSEcCtD
Clofarabine—Dermatitis—Capecitabine—kidney cancer	1.12e-05	0.000155	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—kidney cancer	1.12e-05	0.000155	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ALAD—kidney cancer	1.12e-05	0.000451	CbGpPWpGaD
Clofarabine—Headache—Capecitabine—kidney cancer	1.12e-05	0.000154	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—kidney cancer	1.12e-05	0.000154	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.12e-05	0.000449	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK1—kidney cancer	1.11e-05	0.000448	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—kidney cancer	1.11e-05	0.000154	CcSEcCtD
Clofarabine—RRM2—Metabolism—ABCB1—kidney cancer	1.1e-05	0.000444	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—kidney cancer	1.1e-05	0.000151	CcSEcCtD
Clofarabine—ABCG2—Metabolism—ST3GAL2—kidney cancer	1.09e-05	0.00044	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—kidney cancer	1.09e-05	0.000438	CbGpPWpGaD
Clofarabine—Hypotension—Doxorubicin—kidney cancer	1.08e-05	0.000148	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—kidney cancer	1.07e-05	0.000431	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—kidney cancer	1.07e-05	0.000431	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDH1A1—kidney cancer	1.07e-05	0.00043	CbGpPWpGaD
Clofarabine—Nausea—Capecitabine—kidney cancer	1.06e-05	0.000146	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.05e-05	0.000145	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MAPK3—kidney cancer	1.05e-05	0.000421	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—kidney cancer	1.03e-05	0.000143	CcSEcCtD
Clofarabine—DCK—Metabolism—ABCB1—kidney cancer	1.03e-05	0.000415	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—kidney cancer	1.03e-05	0.000414	CbGpPWpGaD
Clofarabine—Dyspnoea—Doxorubicin—kidney cancer	1.03e-05	0.000142	CcSEcCtD
Clofarabine—ABCG2—Metabolism—PGK1—kidney cancer	1.03e-05	0.000413	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A3—kidney cancer	1.03e-05	0.000413	CbGpPWpGaD
Clofarabine—Somnolence—Doxorubicin—kidney cancer	1.02e-05	0.000141	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.02e-05	0.00041	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—kidney cancer	1.02e-05	0.000408	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LDHB—kidney cancer	1.01e-05	0.000405	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—kidney cancer	1e-05	0.000403	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—kidney cancer	1e-05	0.000138	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MAPK1—kidney cancer	9.97e-06	0.000401	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.94e-06	0.000137	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—kidney cancer	9.92e-06	0.000137	CcSEcCtD
Clofarabine—Pain—Doxorubicin—kidney cancer	9.84e-06	0.000136	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—kidney cancer	9.71e-06	0.000391	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1A1—kidney cancer	9.49e-06	0.000382	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—kidney cancer	9.48e-06	0.000131	CcSEcCtD
Clofarabine—Gastrointestinal pain—Doxorubicin—kidney cancer	9.41e-06	0.00013	CcSEcCtD
Clofarabine—RRM1—Metabolism—POMC—kidney cancer	9.19e-06	0.00037	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—kidney cancer	9.11e-06	0.000366	CbGpPWpGaD
Clofarabine—Body temperature increased—Doxorubicin—kidney cancer	9.1e-06	0.000126	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—kidney cancer	9.1e-06	0.000126	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.81e-06	0.000354	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CA9—kidney cancer	8.72e-06	0.000351	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—kidney cancer	8.69e-06	0.000349	CbGpPWpGaD
Clofarabine—Hypersensitivity—Doxorubicin—kidney cancer	8.48e-06	0.000117	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TP53—kidney cancer	8.37e-06	0.000336	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—kidney cancer	8.26e-06	0.000114	CcSEcCtD
Clofarabine—Pruritus—Doxorubicin—kidney cancer	8.14e-06	0.000112	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—kidney cancer	8.01e-06	0.000322	CbGpPWpGaD
Clofarabine—Diarrhoea—Doxorubicin—kidney cancer	7.87e-06	0.000109	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—kidney cancer	7.79e-06	0.000313	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK1—kidney cancer	7.62e-06	0.000307	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—kidney cancer	7.61e-06	0.000105	CcSEcCtD
Clofarabine—RRM2—Metabolism—POMC—kidney cancer	7.57e-06	0.000305	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CRABP1—kidney cancer	7.42e-06	0.000298	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—kidney cancer	7.33e-06	0.000295	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—kidney cancer	7.32e-06	0.000101	CcSEcCtD
Clofarabine—Rash—Doxorubicin—kidney cancer	7.26e-06	0.0001	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—kidney cancer	7.25e-06	0.0001	CcSEcCtD
Clofarabine—Headache—Doxorubicin—kidney cancer	7.21e-06	9.95e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MAPK3—kidney cancer	7.16e-06	0.000288	CbGpPWpGaD
Clofarabine—DCK—Metabolism—POMC—kidney cancer	7.07e-06	0.000285	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—kidney cancer	6.97e-06	0.00028	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ITPR2—kidney cancer	6.9e-06	0.000277	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—kidney cancer	6.84e-06	9.43e-05	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—MAPK1—kidney cancer	6.82e-06	0.000274	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—kidney cancer	6.39e-06	0.000257	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACHE—kidney cancer	6.29e-06	0.000253	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTT1—kidney cancer	6.29e-06	0.000253	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—kidney cancer	6.04e-06	0.000243	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SCARB1—kidney cancer	5.95e-06	0.000239	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS1—kidney cancer	5.89e-06	0.000237	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PSMD7—kidney cancer	5.78e-06	0.000232	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—kidney cancer	5.72e-06	0.00023	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—kidney cancer	5.64e-06	0.000227	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BCHE—kidney cancer	5.48e-06	0.00022	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—kidney cancer	5.41e-06	0.000218	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—kidney cancer	5.27e-06	0.000212	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A1—kidney cancer	5.23e-06	0.00021	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	4.98e-06	0.0002	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—kidney cancer	4.92e-06	0.000198	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—kidney cancer	4.51e-06	0.000181	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—kidney cancer	4.36e-06	0.000175	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—kidney cancer	4.13e-06	0.000166	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—kidney cancer	4.01e-06	0.000161	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—kidney cancer	3.8e-06	0.000153	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—kidney cancer	3.72e-06	0.000149	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—kidney cancer	3.47e-06	0.00014	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—POMC—kidney cancer	2.83e-06	0.000114	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—kidney cancer	2.26e-06	9.08e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—kidney cancer	1.97e-06	7.92e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—kidney cancer	1.39e-06	5.59e-05	CbGpPWpGaD
